Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

IL-2 plasmid DNA/lipid complex

An immunotherapeutic agent consisting of a plasmid DNA encoding human Interleukin-2 (IL-2) complexed with a cationic lipid, 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE), in a 5:1 ratio. Due to the lipophilic nature of this cation liposome complex, this gene transfer system may improve the efficiency of introducing the IL-2 gene into the cells, thereby increasing the production of IL-2 and inducing an immune response.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:IL-2 plasmid DNA/DMRIE/DOPE lipid complex
interleukin-2 DNA/lipid complex
plasmid DNA IL-2 lipid complex
US brand name:Leuvectin
Code name:VCL-1102
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search